Philippe GENNE

Philippe GENNE, listed as chief executive, has filed trades across 2 companies (mainly through AMF), most often in Oncodesign Precision Medicine S.A. and Oncodesign. The record holds 7 filings, for trades running from 18 October 2022 to 17 April 2025.

The open-market side counts 1 purchase for €117k alongside 5 sales for €293k. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

The record was last updated on 22 April 2025 with a transaction in Oncodesign Precision Medicine S.A. The clock since the last published purchase (8 December 2022) now reads 1,409 days. Typically, a trade is published a median of 5 days after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19). Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.